1PRINETTI A, CHIGORNO V, PRIONI S, et al. Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro[J]. J Biol Chem, 2001, 276 (24): 21136-21145. 被引量：1
2BROWN D A, LONDON E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts[J]. J Biol Chem, 2000, 275(23): 17221-17224. 被引量：1
3OTAROD J K, GOLDBERG I J. Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk[J]. Curr Atheroseler Rep, 2004, 6(5): 335-342. 被引量：1
4SAITO H, ARIMOTO I, TANAKA M, et al. Inhibition of lipoprotein lipase activity by sphingomyelin: role of membrane surface structure[J]. Biochim Biophys Aeta, 2000, 1486(2-3) : 312-320. 被引量：1
5ARIMOTO I, SAITO H, KAWASHIMA Y, et al. Effects of sphingomyelin and cholesterol on lipoprotein lipase- mediated lipolysis in lipid emulsions[J]. J Lipid Res, 1998, 39(1): 143-151. 被引量：1
6VAN ECK M, PENNINGS M, HOEKSTRA M, et al. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis[J]. Curr Opin Lipidol, 2005, 16(3): 307-315. 被引量：1
7BARTER P J, BREWER H B JR, CHAPMAN M J, et al. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atheroselerosis[J]. Arterioseler Thromb Vase Biol, 2003, 23(2): 160-167. 被引量：1
8RYE K A, HIME N J, BARTER P J. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins[J]. J Biol Chem, 1996, 271 (8) : 4243-4250. 被引量：1
9KUMMEROW F A, COOK L S, WASOWICZ E, et al. Changes in the phospholipids composition of the arterial cell can result in severe atherosclerotic lesions [J]. J Nutr Biochem, 2001, 12(10): 602-607. 被引量：1
10SCHISSEL S L, JIANG X, TWEEDIE-HARDMAN J, et al. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atheroselerotic lesion development[J']. J Biol Chem, 1998, 273(5): 2738- 2746. 被引量：1
